Author

Raluca Lupusoru

FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS
FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS

HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?
HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?

PARAMETRIC ARRIVAL TIME (PAT) IN RULING OUT SEVERE LIVER FIBROSIS
PARAMETRIC ARRIVAL TIME (PAT) IN RULING OUT SEVERE LIVER FIBROSIS

HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?
HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?

Raluca Lupusoru  et al.

PARAMETRIC ARRIVAL TIME (PAT) IN RULING OUT SEVERE LIVER FIBROSIS
PARAMETRIC ARRIVAL TIME (PAT) IN RULING OUT SEVERE LIVER FIBROSIS

Raluca Lupusoru  et al.

PREDICTIVE SCORES IN PATIENTS WITH TYPE 2 DIABETES
PREDICTIVE SCORES IN PATIENTS WITH TYPE 2 DIABETES

Raluca Lupusoru  et al.

THE ROLE OF VASCULARIZATION PARAMETERS QUANTIFICATION FOR THE ASSESSMENTS OF INCONCLUSIVE FOCAL LIVER LESIONS CHARACTERIZED BY CEUS
THE ROLE OF VASCULARIZATION PARAMETERS QUANTIFICATION FOR THE ASSESSMENTS OF INCONCLUSIVE FOCAL LIVER LESIONS CHARACTERIZED BY CEUS

Raluca Lupusoru  et al.

FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS
FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS

Raluca Lupusoru  et al.

QUANTIFICATION OF LIVER STEATOSIS USING TWO DIFFERENT ULTRASOUND-BASED METHODS IN COMPARISON WITH CAP
QUANTIFICATION OF LIVER STEATOSIS USING TWO DIFFERENT ULTRASOUND-BASED METHODS IN COMPARISON WITH CAP

Raluca Lupusoru  et al.

PERFORMANCE OF A 2D-SWE IMPLEMENTED ON A NEW ULTRASOUND SYSTEM FOR ASSESSMENT OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AS THE REFERENCE METHOD
PERFORMANCE OF A 2D-SWE IMPLEMENTED ON A NEW ULTRASOUND SYSTEM FOR ASSESSMENT OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AS THE REFERENCE METHOD

Raluca Lupusoru  et al.

PERFORMANCE OF A 2D-SWE FOR THE DIAGNOSIS OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AS REFERENCE METHOD
PERFORMANCE OF A 2D-SWE FOR THE DIAGNOSIS OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AS REFERENCE METHOD

Raluca Lupusoru  et al.

POINT SHEARWAVE ELASTOGRAPHY TECHNIQUES FOR THE ASSESSMENT OF LIVER STIFFNESS
POINT SHEARWAVE ELASTOGRAPHY TECHNIQUES FOR THE ASSESSMENT OF LIVER STIFFNESS

Raluca Lupusoru  et al.

STEATDIAB A SCORE FOR IDENTIFYING TYPE 2 DIABETES MELLITUS PATIENTS AT RISK FOR DEVELOPING MODERATE STEATOSIS
STEATDIAB A SCORE FOR IDENTIFYING TYPE 2 DIABETES MELLITUS PATIENTS AT RISK FOR DEVELOPING MODERATE STEATOSIS

Raluca Lupusoru  et al.

LIVER FIBROSIS AND STEATOSIS ASSESSMENT USING ELASTOGRAPHIC TECHNIQUES: A COMPARISON BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND ALCOHOLIC LIVER DISEASE
LIVER FIBROSIS AND STEATOSIS ASSESSMENT USING ELASTOGRAPHIC TECHNIQUES: A COMPARISON BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND ALCOHOLIC LIVER DISEASE

Raluca Lupusoru  et al.

NONINVASIVE BIOLOGICAL STEATOSIS AND FIBROSIS SCORES, USEFUL TOOLS FOR EVALUATING MAFLD (METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE) PATIENTS
NONINVASIVE BIOLOGICAL STEATOSIS AND FIBROSIS SCORES, USEFUL TOOLS FOR EVALUATING MAFLD (METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE) PATIENTS

Raluca Lupusoru  et al.

Item 1 - 15 / 15
1